Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Surgicraft was a UK-based medical technology company specializing in the design, development, and manufacture of orthopedic and spinal implants. The company's product portfolio included advanced systems for spinal fusion, motion preservation, and fracture fixation, notably the C-STAY and i-PASS spinal systems. Surgicraft established a strong reputation for innovation in the spinal surgery market, providing solutions for degenerative disc disease and complex spinal deformities. In 2011, the company was acquired by Sandvik to expand its MedTech division's footprint in the orthopedic implant sector. Following a subsequent divestment by Sandvik, the business and its technologies were integrated into Orchid Orthopedic Solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surgicraft Group Holdings.